Iterum Therapeutics receives Nasdaq delisting notice for bid price below $1.00

Iterum Therapeutics plc

Nasdaq notice for non-compliance with minimum bid price rule; shares traded below $1.00 for 30 consecutive business days.
180-day cure period expires February 23, 2026; must close at $1.00 for 10 consecutive business days to regain compliance.
May qualify for an additional 180-day period if it meets other listing standards and intends to cure via reverse split.
Failure to cure could lead to delisting; company will monitor options but no assurance of regaining compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.